• BRD4770 and the Translational Logic of G9a Biology

  2026-08-30

  BRD4770 offers translational researchers a practical way to interrogate G9a/EHMT2-dependent chromatin regulation. By reducing intracellular H3K9 methylation, the compound connects epigenetic mechanism with senescence and proliferation phenotypes in PANC-1 cells. This article places those findings alongside breast cancer evidence linking BRD4 and RAC1 inhibition to the c-MYC–G9a–FTH1 axis, while clearly separating pathway context from direct BRD4770 validation. It also provides a decision framework for pharmacodynamic assays, formulation, controls, and responsible interpretation.

• EZ Cap™ Human PTEN mRNA (ψUTP) Workflow

  2026-08-29

  Build reproducible PTEN-restoration assays with Cap 1, pseudouridine-modified, polyadenylated mRNA. This workflow connects formulation, signaling readouts, and trastuzumab-resistance models while providing practical controls for delivery, innate responses, and variable expression.

• ATG4B Links Energy Deficiency to AML DNA Repair Failure

  2026-08-28

  A 2025 Advanced Science study identifies nuclear translocation of ATG4B as a molecular link between energy deficiency, impaired PRMT1–MRE11 DNA repair, and acute myeloid leukemia progression. Its combination of mechanistic cell studies, leukemia models, and patient-derived xenografts suggests that ATG4B inhibition may reduce genomic instability and malignant expansion, although clinical translation remains unresolved.

• Bleomycin Sulfate: From DNA Damage to STING Assays

  2026-08-28

  Bleomycin Sulfate is more than a fibrosis inducer or cytotoxic antibiotic: it can serve as a controlled injury input for testing macrophage-targeted STING interventions. This guide connects DNA strand-break biology with assay design, pulmonary fibrosis research, and translational decision-making.

• AZ505: A Selective SMYD2 Inhibitor

  2026-08-27

  AZ505 is a substrate-competitive SMYD2 inhibitor that targets the peptide-binding groove of the lysine methyltransferase. Its reported biochemical potency, selectivity profile, and activity in cisplatin-associated renal fibrosis models make it a useful tool for epigenetic regulation research and cancer biology research.

• ONX-0914 Workflows for Immunoproteasome Research

  2026-08-27

  ONX-0914 (PR-957) enables selective LMP7 inhibition for dissecting cytokine regulation, immune-cell activation, and disease-relevant proteasome activity. This practical workflow connects PBMC assays with arthritis, diabetes, and exploratory breast cancer studies while emphasizing dose control, matched controls, and interpretation limits.

• Vardenafil HCl Trihydrate for PDE5 Research

  2026-08-26

  Vardenafil HCl Trihydrate supports a connected workflow from nanomolar PDE5 inhibition assays to cGMP-linked smooth muscle studies and proteoform-aware off-target analysis. Its strong PDE5 selectivity, water solubility, and compatibility with native membrane investigations make it useful for both routine pharmacology and mechanism-focused assay development.

• GSK621: Designing AMPK Mechanism Assays

  2026-08-26

  GSK621 is a potent AMPK agonist for connecting target engagement with metabolic, autophagic, and leukemia-cell phenotypes. This guide develops an assay-centered framework that distinguishes direct AMPK activation from the lysosomal 25-hydroxycholesterol pathway described in recent tumor-immunology research.

• Protein A/G Magnetic Co-IP/IP Kit Workflow

  2026-08-25

  The Protein A/G Magnetic Co-IP/IP Kit converts complex immunoprecipitation experiments into a controlled, magnet-based workflow for interaction mapping, post-translational modification studies, and antibody recovery. Its practical value is illustrated by UBC9–PINK1 research, where careful co-IP design can connect a molecular association to mitophagy and oxidative-stress phenotypes.

• Sulfo-Cy3 Azide for Neurodevelopmental Mapping

  2026-08-25

  Sulfo-Cy3 azide is a water-soluble bioconjugation reagent for precise Click Chemistry fluorescent labeling in aqueous neurodevelopmental assays. This guide translates rat claustrum birth-dating data into practical strategies for spatial, temporal, and quantitative fluorescence microscopy.

• Aging Lens Epithelium and Ferroptosis: RSL3 Insights

  2026-08-24

  Wei et al. show that aging lens epithelial cells are unusually vulnerable to ferroptosis, linking age-related cataract biology with altered glutathione, iron, and lipid-peroxidation control. Their use of low-dose erastin and RSL3 across human cells, mouse lens tissue, and transcriptomic analysis provides a framework for studying redox-dependent cell death beyond apoptosis.

• Exosomal Egr2 Protects Neurons via RNF8/DAPK1

  2026-08-24

  This 2025 study identifies exosomal Egr2 from bone marrow mesenchymal stem cells as a protective regulator of oxygen-glucose deprivation/reoxygenation injury in N2a neuronal cells. Its mechanistic model links Egr2-driven RNF8 activation with DAPK1 ubiquitination, offering a testable explanation for how BMSC-derived exosomes may limit neuronal apoptosis after ischemic stress.

• Cl-Amidine: A Decision Framework for PAD4 Studies

  2026-08-23

  Cl-Amidine trifluoroacetate salt enables rigorous investigation of PAD4-dependent histone citrullination, inflammation, and disease biology. This decision-oriented guide connects biochemical assay design with cancer research, rheumatoid arthritis research, and a septic shock murine model while separating direct evidence from experimental interpretation.

• Western Secondary Antibody Dilution Buffer Guide

  2026-08-22

  Improve reproducibility in macrophage atherosclerosis immunoblots with a stabilized secondary-antibody workflow designed for lower background and efficient reagent reuse. This practical guide connects NHE1/Olfr2 mechanism studies with preparation, reuse, optimization, and troubleshooting decisions.

• PEGylated Iron Oxide Nanoparticles in the Liver

  2026-08-21

  This ACS Nano study systematically separates the effects of iron oxide nanoparticle size and PEG chain length on hepatic distribution and cellular uptake. Its combination of 99mTc-SPECT/CT with primary liver-cell assays shows that hepatocytes and stellate cells can contribute substantially to uptake, challenging the assumption that Kupffer cells dominate nanoparticle clearance.

8562 records 1/571 page Next 12345 下5页 Last page